Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Mitochondrial Alterations in Type 2 Diabetes (DIAXO)
NCT02533648Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2011
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol in type 2 diabetes mellitus (T2DM), sponsored by Hospices Civils de Lyon. Started Sep 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02533648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533648.